Antiplatelet therapy in patients undergoing coronary stenting: The risk of late stent thrombosis

Area of Science:

• Cardiology
• Interventional Cardiology
• Biomedical Engineering

Background:

• Anticoagulation is critical post-coronary stenting to prevent stent thrombosis.
• Drug-eluting stents, while preferred, may increase the risk of stent thrombosis.
• Understanding risk factors for late stent thrombosis is crucial for patient management.

Purpose of the Study:

• To investigate the occurrence and potential causes of late stent thrombosis.
• To highlight the importance of adherence to antithrombotic therapy after coronary stenting.
• To evaluate the role of drug-eluting stents in late stent thrombosis.

Main Methods:

• Case series describing patients who developed late stent thrombosis after coronary stent placement.
• Retrospective analysis of patient cases presenting with stent thrombosis.
• Review of medication adherence and clinical outcomes.

Main Results:

• Eight cases of stent thrombosis were identified and analyzed.
• A strong association was observed between early discontinuation of antithrombotic medication and stent thrombosis.
• Drug-eluting stent use was noted in patients experiencing thrombosis.

Conclusions:

• Long-term antithrombotic therapy is essential for preventing stent thrombosis.
• Patients treated with drug-eluting stents may require extended antithrombotic treatment.
• Adherence to prescribed antithrombotic regimens is vital for long-term stent patency.